ExodusPoint Capital Management LP Buys 61,242 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

ExodusPoint Capital Management LP boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1,556.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 65,176 shares of the medical equipment provider’s stock after buying an additional 61,242 shares during the period. ExodusPoint Capital Management LP’s holdings in Intuitive Surgical were worth $34,019,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Norges Bank bought a new stake in shares of Intuitive Surgical in the 4th quarter worth about $2,401,493,000. Proficio Capital Partners LLC raised its position in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after purchasing an additional 948,902 shares during the period. Raymond James Financial Inc. bought a new stake in Intuitive Surgical in the fourth quarter worth about $313,769,000. Wilmington Savings Fund Society FSB boosted its position in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the period. Finally, Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Up 2.2 %

Shares of ISRG opened at $507.05 on Thursday. The firm has a market cap of $180.60 billion, a PE ratio of 79.10, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a fifty day moving average price of $550.11 and a 200-day moving average price of $532.84.

Analyst Ratings Changes

A number of research firms have weighed in on ISRG. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Barclays boosted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. UBS Group raised their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Finally, JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Activity at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 in the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.